January 13, 2020
Generation Bio Completes $100 Million Financing to Advance Re-Dosable Gene Therapy Platform
Read More
January 10, 2020
FDA Approves First Targeted Therapy to Treat Rare Mutation in Patients with GIST
Read More
January 8, 2020
VectivBio Launches with $35 Million to Develop Medicines for Serious Rare Diseases
Read More
January 7, 2020
Deep Genomics Raises $40 Million in Series B Financing
Read More
December 20, 2019
Duke University Establishes Translational Research Collaboration with $130 Million from Deerfield
Read More
December 20, 2019
Ultragenyx Sells Future Royalties on Crysvita for $320 Million
Read More
December 18, 2019
Epirium Raises $85 Million to Develop Treatments for Rare Neuromuscular Diseases
Read More
December 17, 2019
Triplet Therapeutics Launches with $59 Million to Develop Treatments for Repeat Expansion Disorders
Read More
December 10, 2019
Quellis Biosciences Raises $17 Million to Develop Rare Disease Therapies
Read More
December 9, 2019
Jasper Therapeutics Complete $35 Million Financing to Expand Curative Therapies
Read More
December 6, 2019
Limelight Bio Raises $75 Million to Develop Next-Gen Gene Therapies
Read More
November 21, 2019
CRISPR Therapeutics Initiates $275 Million Public Offering
Read More
Load More
X